Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LP-001 by Longbio Pharma (Suzhou) for Anemia: Likelihood of Approval
LP-001 is under clinical development by Longbio Pharma (Suzhou) and currently in Phase I for Anemia. According to GlobalData, Phase...